flow study semaglutide Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes Separate and combined effects of

For Wegovy, the escalation occurs over 16-20 weeks to reach the 2.4 mg maintenance dose

10 seconds for Wegovy) before withdrawing the needle Releasing the skin pinch before withdrawing the needle Avoiding massage or rubbing of the injection site immediately after administration Needle considerations may also impact comfort

Our goal is to create a medical home through the life span for our patients, their family and our community.

GLP-1s mimic a hormone your body already makes

Your body has excess calories, it can break down fat to give energy to you

The results show comparable weight loss as in the STEP 1 trial with injectable semaglutide 2.4mg in obesity branded as Wegovy, said Martin Holst Lange, executive vice president for Development at Novo Nordisk